Five Key Points For China’s Biopharma Development
This article was originally published in PharmAsia News
Executive Summary
A Stanford University scholar recently highlighted five future Chinese biopharma development focuses – medicine invention, promotion of popular drugs, internationalization of sales grids, technology advancement, and state’s nurturing of large businesses.